Investing.com -- Cryptocurrency Injective (INJ) now has its second exchange-traded fund in development after 21Shares filed paperwork with the Securities and Exchange Commission for an Injective ETF ...
Cross-Chain Compatibility: Injective Protocol is designed to be cross-chain compatible, allowing users to trade assets from different blockchain networks seamlessly. This interoperability expands the ...
Approved with 99.89% support, the proposal updates issuance and buyback parameters that govern how INJ is removed from circulation over time. Injective’s protocol community approved a major tokenomics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results